Preparing for the next viral threat with broad-spectrum antivirals

M Karim, CW Lo, S Einav - The Journal of clinical investigation, 2023 - jci.org
There is a large global unmet need for the development of countermeasures to combat
hundreds of viruses known to cause human disease and for the establishment of a …

Pathobiology of Japanese encephalitis virus infection

KB Sharma, S Vrati, M Kalia - Molecular aspects of medicine, 2021 - Elsevier
Japanese encephalitis virus (JEV) is a flavivirus, spread by the bite of carrier Culex
mosquitoes. The subsequent disease caused is Japanese encephalitis (JE), which is the …

[HTML][HTML] Antivirals with common targets against highly pathogenic viruses

L Lu, S Su, H Yang, S Jiang - Cell, 2021 - cell.com
Historically, emerging viruses appear constantly and have cost millions of human lives.
Currently, climate change and intense globalization have created favorable conditions for …

Japanese encephalitis virus: an update on the potential antivirals and vaccines

KS Srivastava, V Jeswani, N Pal, B Bohra… - Vaccines, 2023 - mdpi.com
Japanese encephalitis virus (JEV) is the causal agent behind Japanese encephalitis (JE), a
potentially severe brain infection that spreads through mosquito bites. JE is predominant …

Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism

HY Liu, Z Li, T Reindl, Z He, X Qiu, RP Golden… - Nature …, 2024 - nature.com
Viral genetic diversity presents significant challenges in develo** antivirals with broad-
spectrum activity and high barriers to resistance. Here we report development of proteolysis …

Dengue drug discovery: Progress, challenges and outlook

SP Lim - Antiviral research, 2019 - Elsevier
In the context of the only available vaccine (DENGVAXIA) that was marketed in several
countries, but poses higher risks to unexposed individuals, the development of antivirals for …

Antiviral activity of silymarin and baicalein against dengue virus

ZX Low, BM OuYong, P Hassandarvish, CL Poh… - Scientific Reports, 2021 - nature.com
Dengue is an arthropod-borne viral disease that has become endemic and a global threat in
many countries with no effective antiviral drug available currently. This study showed that …

Therapeutics for flaviviral infections

AM Bifani, KWK Chan, D Borrenberghs, MJA Tan… - Antiviral Research, 2023 - Elsevier
Flaviviruses are vector-borne pathogens capable of causing devastating human diseases.
The re-emergence of Zika in 2016 notoriously led to a widescale epidemic in the Americas …

[HTML][HTML] Development of antiviral carbon quantum dots that target the Japanese encephalitis virus envelope protein

HH Chen, CJ Lin, A Anand, HJ Lin, HY Lin… - Journal of Biological …, 2022 - Elsevier
Japanese encephalitis is a mosquito-borne disease caused by the Japanese encephalitis
virus (JEV) that is prevalent in Asia and the Western Pacific. Currently, there is no effective …

Design, synthesis, in vitro, in silico, and SAR studies of flavone analogs towards anti-dengue activity

A Patigo, K Hengphasatporn, V Cao, W Paunrat… - Scientific Reports, 2022 - nature.com
Flavone has recently been proved as a promising scaffold for the development of a novel
drug against dengue fever, one of the major health threats globally. However, the structure …